B
BDX
BDXUnverified3 segments tracked|7 years of data|Annual (10-K)
Total Revenue
$16.9B206.4%
FY2025
Operating Segments
3Active segments
Blended Margin
34.3%Operating margin
Highest Margin
87.7%Life Sciences
Segment Shift
Life Sciences has grown from 19.7% to 11.1% of total revenue since FY2019, with 87.7% operating margins. Meanwhile, Interventional is the fastest growing at +340.7% YoY.
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2025
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| Medical | $10.1B | $2.7B | 27.2% | 59.5% | +278.6% |
| Interventional | $5.0B | $1.4B | 28.5% | 29.4% | +340.7% |
| Life Sciences | $1.9B | $1.6B | 87.7% | 11.1% | +8.0% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free